Literature DB >> 18728000

Inhibition of protein tyrosine phosphatase 1B and alkaline phosphatase by bis(maltolato)oxovanadium (IV).

Ming Li1, Wenjun Ding, Bharat Baruah, Debbie C Crans, Ruilin Wang.   

Abstract

Vanadate has been recognized as a specific and potent phosphatase inhibitor since its structure is similar to that of phosphate. In this study, we measured the inhibition of glutathione S-transferase-tagged protein tyrosine phosphatase 1B (GST-PTP1B) and alkaline phosphatase (ALP) by the insulin enhancing compounds, bis(maltolato)oxovanadium(IV) (BMOV). The results showed that the activity of GST-PTP1B was reversibly inhibited by solutions of BMOV with an IC(50) value of 0.86+/-0.02 microM. Steady state kinetic studies showed that inhibition of GST-PTP1B by BMOV was of a mixed competitive and noncompetitive type. In addition, incubation of GST-PTP1B with BMOV showed a time-dependent biphasic inactivation of the protein. On the other hand, the inhibitory behavior of BMOV on ALP activity was reversible and competitive with an IC(50) value of 32.1+/-0.6 microM. Incubation with BMOV did not show biphasic inactivation of ALP. The reversible inhibition of GST-PTP1B by BMOV is more potent than that of ALP, but solutions of BMOV inhibited both enzymes. This data support the suggestion that mechanisms for the inhibitory effects of BMOV on GST-PTP1B and ALP are very different.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18728000     DOI: 10.1016/j.jinorgbio.2008.06.007

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  15 in total

1.  Is vanadate reduced by thiols under biological conditions? Changing the redox potential of V(V)/V(IV) by complexation in aqueous solution.

Authors:  Debbie C Crans; Boyan Zhang; Ernestas Gaidamauskas; Anastasios D Keramidas; Gail R Willsky; Chris R Roberts
Journal:  Inorg Chem       Date:  2010-05-03       Impact factor: 5.165

2.  Vanadium compounds discriminate hepatoma and normal hepatic cells by differential regulation of reactive oxygen species.

Authors:  Qin Wang; Tong-Tong Liu; Ying Fu; Kui Wang; Xiao-Gai Yang
Journal:  J Biol Inorg Chem       Date:  2010-05-05       Impact factor: 3.358

3.  Ternary oxovanadium(IV) complexes of ONO-donor Schiff base and polypyridyl derivatives as protein tyrosine phosphatase inhibitors: synthesis, characterization, and biological activities.

Authors:  Caixia Yuan; Liping Lu; Xiaoli Gao; Yanbo Wu; Maolin Guo; Ying Li; Xueqi Fu; Miaoli Zhu
Journal:  J Biol Inorg Chem       Date:  2009-03-17       Impact factor: 3.358

4.  Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1B.

Authors:  Thomas Scior; José Antonio Guevara-García; F J Melendez; Hassan H Abdallah; Quoc-Tuan Do; Philippe Bernard
Journal:  Drug Des Devel Ther       Date:  2010-09-24       Impact factor: 4.162

5.  In vitro and in silico evaluation of the inhibitory effect of a curcumin-based oxovanadium (IV) complex on alkaline phosphatase activity and bacterial biofilm formation.

Authors:  G Katsipis; V Tsalouxidou; E Halevas; E Geromichalou; G Geromichalos; A A Pantazaki
Journal:  Appl Microbiol Biotechnol       Date:  2020-11-16       Impact factor: 4.813

6.  Anti-diabetic effects of a series of vanadium dipicolinate complexes in rats with streptozotocin-induced diabetes.

Authors:  Gail R Willsky; Lai-Har Chi; Michael Godzala; Paul J Kostyniak; Jason J Smee; Alejandro M Trujillo; Josephine A Alfano; Wenjin Ding; Zihua Hu; Debbie C Crans
Journal:  Coord Chem Rev       Date:  2011-10       Impact factor: 22.315

7.  Kinetic characterization of the inhibition of protein tyrosine phosphatase-1B by Vanadyl (VO2+) chelates.

Authors:  Jason Hon; Michelle S Hwang; Meara A Charnetzki; Issra J Rashed; Patrick B Brady; Sarah Quillin; Marvin W Makinen
Journal:  J Biol Inorg Chem       Date:  2017-10-25       Impact factor: 3.358

Review 8.  Metallic ions as therapeutic agents in tissue engineering scaffolds: an overview of their biological applications and strategies for new developments.

Authors:  Viviana Mouriño; Juan Pablo Cattalini; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2011-12-07       Impact factor: 4.118

Review 9.  The metal face of protein tyrosine phosphatase 1B.

Authors:  Elisa Bellomo; Kshetrimayum Birla Singh; Alberto Massarotti; Christer Hogstrand; Wolfgang Maret
Journal:  Coord Chem Rev       Date:  2016-11-15       Impact factor: 22.315

10.  Exploring Oxidovanadium(IV) Complexes as YopH Inhibitors: Mechanism of Action and Modeling Studies.

Authors:  Priscila G A Martins; Mattia Mori; Louise D Chiaradia-Delatorre; Angela C O Menegatti; Alessandra Mascarello; Bruno Botta; Julio Benítez; Dinorah Gambino; Hernán Terenzi
Journal:  ACS Med Chem Lett       Date:  2015-08-31       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.